About OcuMension
OcuMension is a company based in Shanghai (China) founded in 2017.. The company has 489 employees as of December 31, 2024. OcuMension operates in a competitive market with competitors including Annexon, Aldeyra, Nicox, Gyroscope and MeiraGTx, among others.
- Headquarter Shanghai, China
- Employees 489 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
- Legal Name Ocumension Therapeutics
-
Annual Revenue
$58.26 M (USD)66.2as on Dec 31, 2024
-
Net Profit
$-37.45 M (USD)30.69as on Dec 31, 2024
-
EBITDA
$-30.41 M (USD)37.98as on Dec 31, 2024
-
Latest Funding Round
-
Investors
-
Employee Count
489
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of OcuMension
OcuMension is a publicly listed company on the HKEX with ticker symbol 1477 in Hong Kong, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Unlock access to complete
Unlock access to complete
Funding Insights of OcuMension
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investments & Acquisitions by OcuMension
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - OcuMension
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Ocumension Comparisons
Competitors of OcuMension
OcuMension operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Annexon, Aldeyra, Nicox, Gyroscope and MeiraGTx, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Developer of antibodies to treat complement-mediated neurodegenerative diseases
|
|
| domain | founded_year | HQ Location |
Drug candidates for immune-mediated diseases are developed by Aldeyra.
|
|
| domain | founded_year | HQ Location |
Nitric oxide-based therapeutics for glaucoma and eye conditions are developed.
|
|
| domain | founded_year | HQ Location |
Mobile SDK developed for app engagement and monetization strategies.
|
|
| domain | founded_year | HQ Location |
Gene therapies for ocular and neurodegenerative diseases are developed.
|
|
| domain | founded_year | HQ Location |
Ophthalmic pharmaceuticals for diabetic macular edema are developed and commercialized.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Ocumension
Frequently Asked Questions about OcuMension
When was OcuMension founded?
OcuMension was founded in 2017.
Where is OcuMension located?
OcuMension is headquartered in Shanghai, China.
How many employees does OcuMension have?
As of Dec 31, 2024, the latest employee count at OcuMension is 489.
What is the annual revenue of OcuMension?
Annual revenue of OcuMension is $58.26M as on Dec 31, 2024.
What does OcuMension do?
Founded in 2017 and based in Shanghai, China, operations are focused on the ophthalmology sector. A platform for eye medicine development is maintained, with lead candidates including intravitreal implants for uveitis, nitric oxide-based treatments for glaucoma, and therapies for allergic conjunctivitis and macular degeneration. Additional pipeline items address postoperative inflammation, dry eye, blepharitis, ocular hypertension, bacterial infections, corneal rejection, and optic neuritis.
Who are the top competitors of OcuMension?
OcuMension's top competitors include Annexon, Alimera Sciences and MeiraGTx.
Is OcuMension publicly traded?
Yes, OcuMension is publicly traded on HKEX under the ticker symbol 1477.
What is OcuMension's ticker symbol?
The ticker symbol of OcuMension is 1477 on HKEX.